ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,974.07
      0.73%
      US Tech 100
      20,886.00
      0.67%
      Dow Jones
      42,906.95
      0.16%
      Brent Oil
      72.70
      0.00%
      Bitcoin
      94,415.71
      -0.29%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Metagenomi Inc (MGX) Quote

      Metagenomi Inc

      Metagenomi Inc (MGX)

      Mount Gibson Iron Limited
      4.01
      -0.04
      (-0.99%)
      At close: December 23 4:00PM
      Delayed by 15 minutes
      4.07
      0.06
      ( 1.50% )
      After Hours: 6:55PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      4.07
      Bid
      4.00
      Ask
      4.25
      Volume
      1,331,185
      3.825 Day's Range 4.40
      1.61 52 Week Range 12.74
      Market Cap
      152.315M
      Previous Close
      4.05
      Open
      4.11
      Last Trade
      25
      @
      4.07
      Last Trade Time
      18:58:26
      Financial Volume
      $ 5,482,212
      VWAP
      4.1183
      Average Volume (3m)
      1,842,290
      Shares Outstanding
      37,423,917
      Dividend Yield
      -
      PE Ratio
      -2.19
      Earnings Per Share (EPS)
      -1.82
      Revenue
      44.76M
      Net Profit
      -68.26M

      About Metagenomi Inc

      At Metageno-mi, we are cre-at-ing poten-tial-ly cura-tive ther-a-peu-tics using our metage--nomics-pow-ered genome edit-ing toolbox.We believe tools with capa-bil-i-ties that go beyond the cur-rent tech-nol-o-gy land-scape will be required in order to reach the full ther-a-peu-tic poten-tial of geno... At Metageno-mi, we are cre-at-ing poten-tial-ly cura-tive ther-a-peu-tics using our metage--nomics-pow-ered genome edit-ing toolbox.We believe tools with capa-bil-i-ties that go beyond the cur-rent tech-nol-o-gy land-scape will be required in order to reach the full ther-a-peu-tic poten-tial of genome edit-ing. By har-ness-ing the pow-er of metage-nomics, the study of genomes recov-ered from uncul-ti-vat-ed organ-isms in the nat-ur-al envi-ron-ment, we are dis-cov-er-ing and devel-op-ing a suite of nov-el genome edit-ing tools with the poten-tial to make any desired ther-a-peu-tic gene edit, any-where in the human genome. Show more

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.metagenomi.co
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Metagenomi Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker MGX. The last closing price for Metagenomi was $4.05. Over the last year, Metagenomi shares have traded in a share price range of $ 1.61 to $ 12.74.

      Metagenomi currently has 37,423,917 shares outstanding. The market capitalization of Metagenomi is $151.57 million. Metagenomi has a price to earnings ratio (PE ratio) of -2.19.

      Ask ADVFN Intelligence (AI)

      MGX Latest News

      More News

      Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV”

      MGX-001, utilizing a highly specific and efficient MG29-1 nuclease, exhibits no identifiable off-target editing MG29-1 nuclease targeting the albumin safe harbor locus showed no evidence of...

      December 11 2024
      GlobeNewswire Inc.

      Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting

      Therapeutically relevant levels of Factor VIII (FVIII) activity sustained in ongoing nonhuman primate (NHP) study through more than sixteen months of follow up MGX-001 bioengineered FVIII...

      December 09 2024
      GlobeNewswire Inc.

      Form 4 - Statement of changes in beneficial ownership of securities

      December 06 2024
      Edgar (US Regulatory)

      The Gross Law Firm Notifies Metagenomi, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MGX

      The Gross Law Firm Notifies Metagenomi, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MGX PR Newswire NEW YORK, Nov. 22, 2024 NEW YORK, Nov. 22, 2024 /PRNewswire/ -- The Gross...

      November 22 2024
      PR Newswire (US)

      November 25, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MGX

      November 25, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MGX PR Newswire NEW YORK, Nov. 21, 2024 NEW YORK, Nov. 21, 2024 /PRNewswire/ -- The Gross Law Firm issues...

      November 21 2024
      PR Newswire (US)

      Investors who lost money on Metagenomi, Inc.(MGX) should contact The Gross Law Firm about pending Class Action - MGX

      Investors who lost money on Metagenomi, Inc.(MGX) should contact The Gross Law Firm about pending Class Action - MGX PR Newswire NEW YORK, Nov. 18, 2024 NEW YORK, Nov. 18, 2024 /PRNewswire/...

      November 18 2024
      PR Newswire (US)

      Class Action Filed Against Metagenomi, Inc. (MGX) Seeking Recovery for Investors - Contact The Gross Law Firm

      Class Action Filed Against Metagenomi, Inc. (MGX) Seeking Recovery for Investors - Contact The Gross Law Firm PR Newswire NEW YORK, Nov. 14, 2024 NEW YORK, Nov. 14, 2024 /PRNewswire/ -- The Gross...

      November 14 2024
      PR Newswire (US)

      Metagenomi Reports Business Updates and Third Quarter 2024 Financial Results

      Initiating IND-enabling activities for MGX-001 development candidate (DC) in hemophilia A; Achieved durable Factor VIII activity levels over twelve months in nonhuman primate (NHP) study On track...

      November 13 2024
      GlobeNewswire Inc.

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 13 2024
      Edgar (US Regulatory)

      Shareholders that lost money on Metagenomi, Inc.(MGX) should contact The Gross Law Firm about pending Class Action - MGX

      Shareholders that lost money on Metagenomi, Inc.(MGX) should contact The Gross Law Firm about pending Class Action - MGX PR Newswire NEW YORK, Nov. 11, 2024 NEW YORK, Nov. 11, 2024 /PRNewswire/...

      November 11 2024
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.74322.33243162013.3274.142.910122353063.66262983CS
      42.16113.0890052361.914.921.8349359563.98812502CS
      121.8482.51121076232.234.921.6118422903.70934543CS
      260.5214.64788732393.555.49991.619326863.65103187CS
      52-6.18-60.292682926810.2512.741.616050944.27002096CS
      156-6.18-60.292682926810.2512.741.616050944.27002096CS
      260-6.18-60.292682926810.2512.741.616050944.27002096CS

      MGX - Frequently Asked Questions (FAQ)

      What is the current Metagenomi share price?
      The current share price of Metagenomi is $ 4.07
      How many Metagenomi shares are in issue?
      Metagenomi has 37,423,917 shares in issue
      What is the market cap of Metagenomi?
      The market capitalisation of Metagenomi is USD 151.57M
      What is the 1 year trading range for Metagenomi share price?
      Metagenomi has traded in the range of $ 1.61 to $ 12.74 during the past year
      What is the PE ratio of Metagenomi?
      The price to earnings ratio of Metagenomi is -2.19
      What is the cash to sales ratio of Metagenomi?
      The cash to sales ratio of Metagenomi is 3.34
      What is the reporting currency for Metagenomi?
      Metagenomi reports financial results in USD
      What is the latest annual turnover for Metagenomi?
      The latest annual turnover of Metagenomi is USD 44.76M
      What is the latest annual profit for Metagenomi?
      The latest annual profit of Metagenomi is USD -68.26M
      What is the registered address of Metagenomi?
      The registered address for Metagenomi is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
      What is the Metagenomi website address?
      The website address for Metagenomi is www.metagenomi.co
      Which industry sector does Metagenomi operate in?
      Metagenomi operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      CREVCarbon Revolution Public Ltd
      $ 8.68
      (123.14%)
      		808.99k
      NCRANocera Inc
      $ 1.43
      (60.58%)
      		3.72M
      MYNAMynaric AG
      $ 0.6486
      (47.53%)
      		6.88M
      BNOXBionomics Ltd
      $ 0.37
      (46.19%)
      		6.35M
      TIVCTivic Health Systems Inc
      $ 0.2825
      (25.89%)
      		6.67M
      SLGLSol Gel Technologies Ltd
      $ 1.0991
      (-33.39%)
      		3.66M
      ANEBAnebulo Pharmaceuticals Inc
      $ 1.0201
      (-18.39%)
      		2.65k
      JZXNJiuzi Holdings Inc
      $ 1.45
      (-12.12%)
      		312
      VIVKVivakor Inc
      $ 1.16
      (-11.45%)
      		240
      TAOPTaoping Inc BVI
      $ 0.3725
      (-11.31%)
      		182.61k
      TNXPTonix Pharmaceuticals Holding Corporation
      $ 0.4331
      (7.44%)
      		14.35M
      DRCTDirect Digital Holdings Inc
      $ 6.33
      (15.09%)
      		12.75M
      MYNAMynaric AG
      $ 0.6486
      (47.53%)
      		6.88M
      TIVCTivic Health Systems Inc
      $ 0.2825
      (25.89%)
      		6.67M
      BNOXBionomics Ltd
      $ 0.37
      (46.19%)
      		6.35M

      MGX Discussion

      View Posts
      Landwehr Landwehr 2 days ago
      There hasn't been any news in a while. However, the chart is looking really good
      👍️0
      Monksdream Monksdream 2 days ago
      MGX under $5

      [color=red][/color]
      👍 1
      Landwehr Landwehr 3 days ago
      MGX still looking good. A mild new release will send this to 4.5. 
      👍️0
      TrendTrade2016 TrendTrade2016 5 days ago
      GAVE IT A CHANCE...SOLD IT
      👍️0
      Landwehr Landwehr 5 days ago
      We need a news release for this to go back up. I'm long on this stock 
      👍️0
      TrendTrade2016 TrendTrade2016 5 days ago
      MGX GAPPING BACK UP...LAST ATTEMPT
      👍️0
      Landwehr Landwehr 6 days ago
      If we can continue to consolidate and churn in this range for a few days we will be in good shape for the next news cycle. 
      👍️0
      TrendTrade2016 TrendTrade2016 6 days ago
      5 DAY DOWN TREND SEEMS TO HAVE STOPPED
      👍️0
      Landwehr Landwehr 6 days ago
      Very good consolidation while no new news
      👍️0
      TrendTrade2016 TrendTrade2016 6 days ago
      MGX BUILDING A FOUNDATION
      👍 1
      Landwehr Landwehr 1 week ago
      The next news release will ignite this stock. 
      👍️0
      dinogreeves dinogreeves 1 week ago
      No, they are well funded well into 2025 and even beyond late 2025.
      👍️0
      Millenium323 Millenium323 1 week ago
      Bayer Healthcare bought a 10.8% stake in $MGX according to a Nov 6th filing. Bayer is a multibillion dollar company who is known for their Hemophilia Division. This happens to correspond to MGX's strength which is their Hemophilia pipeline

      https://www.otcmarkets.com/filing/html?id=17946805&guid=3xY-kK_WErmSJth
      👍 1
      Landwehr Landwehr 1 week ago
      This is going to be a fun ride. Alot of volatility. It will get back close to 10 in the next couple months. Even if it's speculation 
      👍️0
      dinogreeves dinogreeves 2 weeks ago
      I sold at $4.50.
      👍️0
      frans frans 2 weeks ago
      MGX need money ???
      👍️0
      frans frans 2 weeks ago
      MGX company work for MM not for shaholders and selling shares into market
      👍️0
      frans frans 2 weeks ago
      all schort what I see on my L2 MM's 10 - 12 sametime
      👍️0
      theorysuit theorysuit 2 weeks ago
      This is how these bios move. You get the early stage upwave which we are in. They will bring it down closer to commercialization again. Ride this upwave and expect periods of pullbacks and consolidation.
      👍️0
      Landwehr Landwehr 2 weeks ago
      I wouldn't consider this stock a pump and dump. I do agree on the way to the 52 week low that shook alot of weak hands. Now with three sources of revenue and some of their products entering a new phase before production, this stock is getting noticed 
      👍️0
      frans frans 2 weeks ago
      I am not out I am long
      👍️0
      theorysuit theorysuit 2 weeks ago
      Stage 1 pump. They shook everyone out on the drive to 1.60. This is how stocks move.
      👍️0
      Landwehr Landwehr 2 weeks ago
      A ride to $10
      👍️0
      frans frans 2 weeks ago
      what is going on here ??
      👍️0
      TrendTrade2016 TrendTrade2016 2 weeks ago
      MGX MONSTER
      👍️0
      dinogreeves dinogreeves 2 weeks ago
      This is why it ran today with no news, someone knew it was coming

      https://finance.yahoo.com/news/metagenomi-presents-updated-preclinical-data-021600360.html
      👍️0
      dinogreeves dinogreeves 2 weeks ago
      Corporate presentation just an hour ago.

      https://dbzipdrh8te83.cloudfront.net/MGX-ASH-December-2024.pdf
      👍️0
      dinogreeves dinogreeves 2 weeks ago
      Great update! Hemophilia drug market was estimated to be 12.1 billion this year. 18.7 billion by 2034. I wonder how much they’ll charge for a cure….. or governments will pay for it. Amazing opportunity here. Stoked for the years ahead.
      👍️0
      dinogreeves dinogreeves 2 weeks ago
      https://metagenomi.co/discovery-platform
      👍️0
      dinogreeves dinogreeves 2 weeks ago
      This has 8-10 dollars written all over it in a week. Gene therapy is huge market, very huge.
      👍️0
      dinogreeves dinogreeves 2 weeks ago
      Yup, this is real good one, I am still holding. Bought, then went out of the house to run errands. Over 7 dollars book value and revenues.
      👍 1
      Monksdream Monksdream 2 weeks ago
      Metagenomi, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene edit­ing toolbox, ther­a­peu­tic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA. The listed name for MGX is Metagenomi, Inc. Common Stock
      👍️0
      Monksdream Monksdream 2 weeks ago
      UP OFF THE MAT, maybe it will grow legs
      👍️0
      Landwehr Landwehr 2 weeks ago
      This could get to $5 this week
      👍️0
      glenn1919 glenn1919 2 weeks ago
      MGX..................https://stockcharts.com/h-sc/ui?s=MGX&p=W&b=5&g=0&id=p86431144783
      👍 1
      eur06 eur06 2 weeks ago
      Just got on line….it looks pretty good!!
      Trying to get some.
      👍️0
      theorysuit theorysuit 2 weeks ago
      LfG!
      👍️0
      dinogreeves dinogreeves 2 weeks ago
      Will run to 10 dollars within a week. Insiders and Tutes bought above 10 dollars.
      👍 1
      TrendTrade2016 TrendTrade2016 2 weeks ago
      mgx blowing up
      👍️0
      dinogreeves dinogreeves 2 weeks ago
      1000% gains coming here, jumped in at 2.28 this morning with 4000 shares.
      👍 1
      KIPK KIPK 3 months ago
      POS ....You are
      👍️0
      KIPK KIPK 3 months ago
      You are a POS dude....
      👍️0
      theorysuit theorysuit 4 months ago
      Added again here in full size. Data looks fantastic.
      👍️0
      theorysuit theorysuit 4 months ago
      https://finance.yahoo.com/news/metagenomi-announces-preclinical-data-lead-200500503.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr

      Efficacy and Durability looks promising here. Lotto sized play here sub $3. I think Stage 1 Pump incoming. A deal to replace MRNA would be nice.
      👍️0
      theorysuit theorysuit 4 months ago
      buying in small chunks under $3.
      👍️0
      theorysuit theorysuit 4 months ago
      i'm buying it up as speculative play on cash value. Will hold a tight stop loss.
      👍️0
      theorysuit theorysuit 5 months ago
      every stock that i look into, you are here :)
      👍️0
      jondoeuk jondoeuk 8 months ago
      The IPO was way too early, and one of the few pillars of its business plan was the partnership. The fact that Moderna walked away means that has collapsed. In the future, IP could be another issue.
      👍️0
      jondoeuk jondoeuk 8 months ago
      Try not to end up being a bag holder for VC's shifting overvalued ''dream companies.''
      👍️0
      jondoeuk jondoeuk 8 months ago
      MRNA walks away from the deal that could have generated up to $3B, handing back full global rights and related technologies.
      👍️0

      Your Recent History

      NASDAQ
      MGX
      Metagenomi
      BIT
      UBM
      Ulisse Biomed
      BOV
      RZZV11
      Raizz Desenvolvimento I ...
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads